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ABSTRACT 30	
Compression garments are frequently used to facilitate recovery from strenuous exercise.  31	
Purpose: To identify the effects of two different grades of compression garment on recovery 32	
indices following strenuous exercise.  Methods: Forty five recreationally active participants 33	
(n=26 males and n=19 females) completed an eccentric exercise protocol consisting of 100 34	
drop jumps. Following the exercise protocol participants were matched for body mass and 35	
randomly but equally assigned to either a high (HI) compression pressure group, a low 36	
(LOW) compression pressure group, or a sham ultrasound group (SHAM).  Participants in 37	
the high (HI) and low (LOW) compression groups wore the garments for 72 h post-exercise; 38	
participants in the SHAM group received a single treatment of 10 minutes sham ultrasound.  39	
Measures of perceived muscle soreness, maximal voluntary contraction (MVC), counter 40	
movement jump height (CMJ), creatine kinase (CK), C-reactive protein (CRP) and 41	
myoglobin (Mb) were assessed before the exercise protocol and again at 1, 24, 48 and 72 h 42	
post exercise. Data were analysed using a repeated measures ANOVA.  Results: Recovery of 43	
MVC and CMJ was significantly improved with the HI compression garment (p < 0.05).  A 44	
significant time by treatment interaction was also observed for jump height at 24 h post 45	
exercise (p < 0.05).  No significant differences were observed for parameters of soreness and 46	
plasma CK, CRP and Mb.  Conclusions: The findings of this study indicate that the pressures 47	
exerted by a compression garment affect recovery following exercise-induced muscle damage 48	
(EIMD), with a higher pressure improving recovery of muscle function.  49	
 50	
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INTRODUCTION 61	
Exercise that is unaccustomed or unfamiliar in nature can lead to the experience of exercise-62	
induced muscle damage (EIMD) (1,2).  Symptoms associated with EIMD include decreased 63	
force production, decreased range of motion (ROM) and the experience of muscle soreness, 64	
all of which can negatively affect performance (3).  Consequently, there is a growing interest 65	
in strategies that can minimise the experience of EIMD and accelerate recovery. 66	
 67	
Compression garments are often used to aid recovery following strenuous exercise.  The use 68	
of compression originates from clinical settings where limb compression is used to treat a 69	
range of inflammatory conditions including lymphedema (4), deep vein thrombosis (5) and 70	
chronic venous insufficiency (6).  Research investigating the use of compression as a 71	
recovery modality in an athletic setting remains equivocal, with some research indicating 72	
favourable effects (7-10) and other research reporting no benefits (11-12).  Whilst the exact 73	
mechanism for the benefit of compression garments remains unclear it is thought that 74	
application of compression can positively affect haemodynamics and attenuates swelling by 75	
facilitating lymphatic drainage and reducing the increase in osmotic pressure experienced as a 76	
result of tissue damage (13).  In addition, compression is thought to provide mechanical 77	
support to the injured limb which may in turn prevent force decrements (13). 78	
 79	
One methodological disparity between studies is the level of compression exerted by the 80	
garment.  It is likely that the effects of a compression garment depend on the amount of 81	
compression applied (14), however if the degree of compression exerted by the garment is 82	
insufficient or too high, a beneficial effect is unlikely (15-16). Low levels of compression 83	
may be insufficient to modulate blood flow or osmotic pressure, and levels of compression 84	
that are too high may have a restrictive effect on blood flow.  Optimal levels of compression 85	
beneficial to performance and recovery have yet to be determined, with current 86	
recommendations based upon clinical guidelines (17).  However, pressures that are effective 87	
in a clinical population may not be effective in an athletic population.   88	
 89	
Improved venous return has been observed at pressures of 20-25 mmHg at the calf and thigh 90	
respectively, with the authors of this study proposing pressures of 15.2-17.3 mmHg as the 91	
minimum required in order to achieve elevations in venous return (18). However it should be 92	
noted that these minimum pressures are estimations, calculated by assessing the cardiac 93	
output response to three different levels of compression garments (10-8, 15-12 and 20-16 94	
mmHg at the calf and thigh respectively). Sperlich et al. (19) investigated the effects of knee-95	
high socks that applied compression pressures of 0, 10, 20, 20 and 40 mmHg and observed no 96	
effect at any pressure on cardio-respiratory and metabolic parameters during submaximal 97	
running. In contrast to this, another study indicated that compression garments exerting 98	
pressures of 20 and 40 mmHg may improve alpine skiing performance by enabling a deeper 99	
tuck position with attenuated perceived exertion; however the authors indicated that the 100	
garment exerting 40 mmHg may reduce blood flow (20). 101	
 102	
A variety of compression pressures have been used in current research ranging from 10-12 103	
mmHg (21) up to 40 mmHg (19).  A major limitation with current research investigating the 104	
efficacy of compression is that a large number of studies have failed to measure exact 105	
interface pressures applied by the garments (4, 22-25).  Previous research has highlighted 106	
large variations in the degree of pressure exerted by compression garments across a 107	
population, with a number of individuals receiving low levels of compression (26).  This 108	
variation is likely due to differences in limb size and tissue structure within a particular size 109	
category of garment (22). Thus it is possible the degree of compression exerted was 110	
insufficient to enhance recovery in several studies that have observed no benefit (2).  111	
Knowledge of the pressures applied by compression garments is fundamental to developing 112	
understanding on how a garment affects parameters of performance and recovery.  Without 113	
knowledge on the precise pressures applied in research studies we cannot accurately interpret 114	
or compare findings (15).   Therefore the aim of this investigation was to assess whether 115	
garments exerting a higher degree of pressure are more effective in facilitating recovery 116	
compared to garments exerting a lower pressure.    117	
 118	
 119	
METHODOLOGY 120	
Participants 121	
Forty five recreationally active participants from any sport or training background (n=26 122	
male, n=19 female) volunteered to participate in this study.  Following ethical approval all 123	
participants completed a health screening questionnaire and gave written informed consent.  124	
Individuals with a history of musculoskeletal injury and inflammatory disorders were 125	
excluded from participating in this study.  All participants were asked to arrive at the 126	
laboratory in a rested state  and refrain from heavy exercise in the 48 h preceding the study 127	
and for 72 h following the muscle damaging protocol; in addition, participants were required 128	
to refrain from using any recovery strategy for the duration of the investigation.  Participant 129	
characteristics are presented in table 1. 130	
 131	
Experimental overview  132	
Participants were matched for weight and randomly, but equally assigned, to either a low 133	
(LOW, n=15), or high (HI, n=15) compression treatment group, or a sham-ultrasound group 134	
(SHAM, n=15).  Participants reported to the laboratory for familiarisation and baseline 135	
testing 1 h prior to the muscle damaging protocol.  During the familiarisation participants 136	
were given a full verbal explanation of how each variable was to be measured and were 137	
required to undertake practice attempts of the muscle function tests until performance in each 138	
of the tests reached a plateau.  Following the familiarisation participants sat with their feet up 139	
for 20minutes before the collection of baseline data commenced. Base line data was collected 140	
for the dependent variables creatine kinase (CK), high sensitivity C-reactive protein (CRP), 141	
myoglobin (Mb), global lower limb muscle soreness and quadriceps soreness, counter 142	
movement jump (CMJ), and maximum voluntary contraction (MVC) of the knee extensors.  143	
These variables were analysed again 1, 24, 48 and 72 h post muscle damaging protocol.  144	
Participants were required to attend the laboratory for post testing at the same time of day and 145	
variables were always collected in the same order.  146	
 147	
Muscle damage procedure  148	
The muscle damaging protocol consisted of 100 drop jumps from a 0.6 m platform.  149	
Participants performed 5 sets of 20 drop jumps, with 10 seconds between each jump and a 2 150	
minute rest period between sets. Participants were instructed to jump maximally upon landing 151	
each jump.   152	
 153	
Treatment groups  154	
Participants in the LOW compression group were fitted with a full length, lower limb, 155	
commercially available compression garment (MA1551b men’s compression tights, 2XU, or 156	
WA1552b women’s compression tights, 2XU, Melbourne, Australia) fitted according to 157	
manufacturer’s guidelines based upon participants’ height and weight.   Pressure exerted by 158	
the compression garment was measured using a pressure-measuring device (Kikuhime, TT 159	
Medi Trade, Søleddet, Denmark), validated for use in this setting (6).  Pressure was measured 160	
at the front thigh at the mid-point between the superior aspect of the patella and the inguinal 161	
crease and at the medial aspect of the calf at the site of maximal girth.   Measurements were 162	
taken at each site whilst the subject was standing in the anatomical position.   Measurements 163	
were repeated three times with the mean value recorded.  Average pressures exerted by the 164	
garments were reported as 8.1 ± 1.3 mmHg at the thigh and 14.8 ± 2.1 mmHg at the calf.   165	
 166	
Participants in the HI compression group wore a full length lower limb clinical medical grade 167	
II compression garment (Alleviant clinical class II medical stockings, Jobskin, Nottingham, 168	
UK) fitted according to manufacturer’s guidelines based upon leg circumference measured at 169	
7 locations on the leg.  These garments exerted an average pressure of 14.8 ± 2.2 mmHg at 170	
the thigh and 24.3 ± 3.7 mmHg at the calf.  All garments were worn for 72 h post exercise, 171	
participants were only allowed to remove them to shower.  Participants were each given two 172	
pairs of the same garments to allow rotation when washing.    173	
 174	
Participants in SHAM received 10 min of sham ultrasound comprised of 5 minutes each thigh 175	
(Combined therapy ultrasound/inferential, Shrewsbury Medical, Shropshire, UK).  A water 176	
soluble ultrasound gel (Aquasonic 100 ultrasound transmission gel, Parker Laboratries, 177	
Fairfield, USA) was applied to the thigh, using the ultrasound head the gel was spread across 178	
the skin using circular movements. Throughout the duration of the ultrasound treatment the 179	
unit was turned off and obscured from view of the participants.  All treatments were applied 180	
immediately following the muscle damaging protocol. 181	
 182	
Dependent variables 183	
Muscle soreness: Global lower limb muscle soreness and localised soreness in the 184	
quadriceps muscle group was analysed using a 200 mm visual analogue scale (VAS) with ‘no 185	
pain’ at 0 mm and ‘unbearable pain’ at 200 mm.  Participants stood with their feet shoulder 186	
width apart with hands on hips and were asked to perform a squat to 90°, return to standing 187	
and mark their subjective feelings of pain on the scale. 188	
 189	
Muscle function: Maximal voluntary contraction was assessed using a strain gauge (MIE 190	
Medical Research Ltd., Leeds, UK).  Participants were seated on a platform in a standardised 191	
position, with their hip and knee joints flexed at 90°. The strain gauge was attached 2 cm 192	
above the malleoli of the left ankle and participants were required to maximally extend the 193	
knee against the device for 3 s, verbal encouragement was given for the duration. Participants 194	
performed three repetitions, each separated by 1 min, with the greatest value recorded as 195	
MVC.   Measurements were recorded in newtons.  196	
 197	
Counter movement jump height was assessed using a force plate (Kistler 9287BA force 198	
platform, Kistler Instruments Ltd, Hamshire, UK).  Participants were instructed to stand with 199	
their hands on their hips and perform a maximal jump on command.  Participants performed 200	
three jumps the best of which was taken for analysis.  Data from 5 participants (n=2 LOW, 201	
n=1 HI and N=2 SHAM) were not included in the jump data analysis due to technical issues 202	
with the equipment. 203	
 204	
Blood measures: CK, high sensitivity CRP, and Mb were analysed from plasma blood 205	
samples.  Approximately 8.5 mL of blood was collected from the antecubital vein into 206	
lithium heparin vacutainers.  Following collection, the sample was immediately placed in a 207	
refrigerated centrifuge and spun at 3500 rpm, a relative centrifugal force of 3000 g, for 20 208	
minutes at 4°C to enable the separation of plasma.  The plasma was immediately frozen at -209	
80°C for later analysis.  Plasma CK and CRP Mb were measured using an automated 210	
analyser (Advia 2400, Chemistry System, Siemens Health Care Diagnostics, USA).  211	
Manufacturer’s report an intra-sample CV for the analyser of <3% at high and low 212	
concentrations and expected baseline sample ranges of 32-294 IU.L-1 and < 3 pg.mL-1 for CK 213	
and CRP, respectively. Plasma Mb was analysed using an electrochemiluminescence immuno 214	
assay (ECLIA) (Elecsys 2010, Roche Diagnostics GmbH, Germany). Manufacturer’s report 215	
an intra-sample CV for the analyser of <4% and expected values of 25-72ng.ml-1. 216	
 217	
Statistical Analysis  218	
All data analyses was carried out using SPSS for Windows version 21, and values are 219	
reported as mean ± SD. Independent samples t-tests were used  to identify any differences in 220	
group characteristics at baseline.  All dependent variables were assessed using a treatment by 221	
time repeated measures analysis of variance (ANOVA).  Where a significant effect was 222	
observed, interaction effects were further examined using a Bonferroni post hoc analysis.  A 223	
significance level of p ≤ 0.05 was applied throughout.  Effect sizes, using Cohen’s d, and 224	
90% confidence intervals (CI) were calculated to assess magnitude of effect on the change 225	
from baseline at 1, 24, 48 and 72 h post exercise. Threshold values were set at 0.2, small; 0.5, 226	
moderate; and 0.8, large. 227	
  228	
 229	
RESULTS 230	
Effect sizes and 90% CI comparing change from baseline with 1, 24, 48 and 72 h post 231	
exercise can be seen for each variable in table 2. A significant time effect was observed for 232	
global lower limb muscle soreness (F2.639,1=31.509, p < 0.001) and soreness of the quadriceps 233	
(F2.988,1=45.865, p < 0.001) indicating that there was a change in muscle soreness over time.  234	
Further post hoc Bonferroni tests indicated significant differences from baseline occurred at 235	
all time points in both global and quadriceps soreness (p < 0.05).   No significant group (F2, 42 236	
=1.081, p = 0.325) or interaction effects (F5.278,2=0.861, p = 0.515) were observed for global 237	
lower limb soreness.  This was consistent with the group (F2,42=0.972, p = 0.387) and 238	
interaction effects observed for quadriceps soreness (F5.976, 2  =0.855, p = 0.530) (Figures 1a 239	
and 1b).   240	
 241	
Significant time effects were observed for MVC (F3.084, 1=49.760, p < 0.001), Bonferroni post 242	
hoc tests indicated that a significant difference from baseline occurred at all time points (p < 243	
0.05).  Values reduced to 81.6 ± 9.0, 84.3 ± 6.3 and 81.4 ± 9.2 % of baseline 1 h after the 244	
damaging protocol and returning to 90.6 ± 11.6, 99.9 ± 9.9 and 91.2 ± 9.7% of baseline at 72 245	
h post in the LOW, HI and SHAM groups respectively.  A significant treatment effect was 246	
observed for MVC (F2,42  = 3.832, p = 0.030), however there was no significant time by 247	
treatment interaction (F6.169,2 = 1.824, p = 0.097).  Further post hoc analysis indicated the 248	
significant difference occurred between the HI and SHAM groups (p = 0.036) (figure 2).   249	
 250	
Significant time effects were observed for Jump height (F4,1 = 11.202, p < 0.001), further post 251	
hoc analysis indicated that significant differences from baseline occurred at all time points (p 252	
< 0.05) figure 3.  A significant time by treatment effect (F8,2 = 2.99, p  = 0.004) and a 253	
significant treatment effect (F2,37 = 3.741, p = 0.33) was observed for jump height. Further, 254	
post hoc analysis indicated the significant treatment effect occurred between the HI and LOW 255	
compression groups (p = 0.032) and the time by treatment interaction occurred at 24 h post 256	
exercise between the HI and LOW compression groups (p = 0.002) (figure 3). 257	
  258	
Whilst an overall significant time effect was observed for CK (F2.353,1 = 2.980, p = 0.021), 259	
further post hoc analysis failed to indicate a significant effect at any time point  (p > 0.05).  260	
Post exercise plasma CK values were elevated 1 h post exercise in all experimental groups 261	
and remained raised for the duration of the study.   No significant group (F2,42 = 0.174, p = 262	
0.841) or interaction effects were observed for CK (F4.706,2 = 1.383, p = 0.240), data is 263	
presented in table 3.   264	
 265	
There was no significant time effect (F4,1  = 0.615, p = 0.570), group effect (F2,11 = 0.511, p = 266	
0.558) or time by group effect (F8,2 = 0.217, p = 0.858) for CRP. This was also consistent 267	
with Mb where there was also no significant time (F4,1  = 1.915, p = 0.110), group (F2,11 = 268	
0.387, p = 0.681) or time by group effect (F8,2 = 1.016, p = 0.462) (table 3). 269	
 270	
 271	
DISCUSSION  272	
The aim of this study was to investigate the effects of different compression pressures on 273	
indices of recovery following EIMD in a recreationally active population.  The main finding 274	
was that a garment exerting higher levels of compression is more effective in modulating 275	
muscle function following exercise that induces muscle damage when compared to a garment 276	
exerting lower levels of compression and a sham treatment group.   277	
 278	
In this study muscle function decreased following the damaging protocol, this was evidenced 279	
by a significant time effect for both MVC and jump height (p<0.05).  Recovery of strength 280	
was greatest in the HI compression group with participants recovering to 99.9 ± 9.9% of 281	
baseline MVC values at 72 h post exercise compared to 90.6 ± 11.6 and 91.2 ± 9.7% in the 282	
LOW and SHAM group. A significant difference between treatment groups was observed for 283	
MVC with the difference occurring between the HI compression group and the SHAM group  284	
This observation is supported by the large effect sizes observed between the HI and SHAM 285	
group between 24 – 72 h post exercise and the moderate to large effect sizes observed 286	
between the LOW and HI group at the same time points. These observations suggest that 287	
strength recovered at an accelerated rate over 72 h in the HI compression group.   288	
 289	
Additionally Jump height was significantly higher 24 h post exercise in the HI group 290	
compared to the LOW group, indicating that compression garments exerting higher levels of 291	
compression may be beneficial in improving recovery of muscle function.  The failure to 292	
observe a significant treatment effect between the HI and SHAM group was unexpected, 293	
however a large effect size was seen at 24h post exercise.  Although this study attempted to 294	
control for a placebo effect by using sham ultrasound, it is possible that the observation of 295	
improved recovery in the HI group may be linked to the participant’s belief that tighter 296	
compression garments have a positive response on recovery; this is a limitation of the study.  297	
 298	
Improved recovery of muscle function has been observed in previous research (9,13,27), and 299	
has been attributed to an enhanced repair of the contractile elements of the muscle (13).  300	
Furthermore the application of compression may provide mechanical support to the limb 301	
resulting in reduced movement of the tissues and offering ‘dynamic immobilisation’, whilst 302	
still enabling use of the limb, this has been proposed to increase motor unit activation during 303	
tissue injury (13, 28).  However, the exact mechanism responsible for this is unclear.  Several 304	
studies have failed to observe improved muscle function with the use of a compression 305	
garment (11,21-22).  However as the exact level of compression exerted by the garments was 306	
not measured in these studies it is possible the garments used did not exert enough pressure to 307	
be of benefit. 308	
 309	
No significant between group differences were observed for global lower limb soreness and 310	
soreness in the quadriceps, this is similar to previous findings (11-12,21). However, moderate 311	
effect sizes were observed at 48 h post exercise between the HI and SHAM group for global 312	
muscle soreness and at 24 h post exercise between the LOW and HI group for quadriceps 313	
muscle soreness, indicating soreness was lower in the HI group.   314	
 315	
The experience of DOMS arises as a result of damage to the soft tissue leading to an 316	
inflammatory response which causes localised oedema in the affected limb.  The presence of 317	
oedema can stimulate pain afferents bringing about the experience of soreness (28).  The 318	
application of compression may reduce the level of oedema by attenuating the magnitude of 319	
the inflammatory response thus reducing the severity of the soreness experienced (21,27).  320	
Whilst a large body of research has observed reductions in perceived muscle soreness with 321	
the use of compression garments (13,24,27), these studies failed to control for placebo effect, 322	
this needs to be considered when interpreting findings.   323	
 324	
Creatine kinase and Mb are released from the muscle during the experience of muscle 325	
damage and as such are frequently used as markers of EIMD (21-22).  Given the absence of a 326	
significant time effect for Mb and a non-significant post hoc results for the time effect in CK 327	
it is likely that the muscle damage protocol in this study did not cause sufficient enough 328	
muscle damage for a large CK and Mb response.  Previous investigations have observed 329	
reductions in concentrations of CK with the application of compression (2,22).  It is worth 330	
noting the peak concentrations of CK observed within the control group of this study (586 331	
IU.L-1), is much smaller than the values observed in other studies (2194 IU.L-1(7) and ~1750 332	
IU.L-1 (13)) all of whom found beneficial effects of compression. It is possible compression is 333	
not effective at modulating clearance of CK at lower concentrations.   334	
 335	
A number of investigations have observed reduced inflammation with the use of a 336	
compression garment (9,13,21), however this study failed to observe any significant group 337	
differences for the inflammatory marker CRP.  Furthermore no significant time effect was 338	
observed for this marker, it is possible that muscle damage was not severe enough to cause a 339	
large inflammatory response. Regardless of the magnitude of the inflammatory response it 340	
appears the exercise protocol was severe enough to cause pronounced performance 341	
decrements and elevations in muscle soreness.   342	
 343	
 344	
PRACTICAL APPLICATION 345	
Whether compression garments exert sufficient pressure to be effective has been raised by a 346	
number of investigators (21-22). This study provides evidence for the importance of 347	
compression pressure in modulating parameters of recovery.  The majority of previous 348	
research has failed to measure exact pressures exerted by compression garments, until the 349	
reporting of interface pressure occurs in research on compression it is difficult to identify 350	
optimal levels of compression necessary for improving recovery.  More knowledge is needed 351	
on the effects of different compression pressures in order to assist practitioners in the 352	
selection of a garment for a particular role.  353	
 354	
 355	
CONCLUSIONS 356	
In conclusion, a compression garment exerting higher compression pressures (14.8 ± 2.2 and 357	
24.3 ± 3.7 mmHg at the thigh and calf respectively) is more effective at improving muscle 358	
function than a compression garment exerting lower pressures (8.1 ± 1.3 mmHg at the thigh 359	
and 14.8 ± 2.1 mmHg at the calf) and a SHAM treatment group. Furthermore, no treatment 360	
group was superior in aiding the removal of plasma markers of muscle damage or 361	
inflammation.  The degree of pressure exerted by the garment is an important factor in 362	
determining the efficacy of compression garments in recovery.  These findings highlight the 363	
importance of wearing a correctly fitting garment when using compression as a recovery 364	
modality.  365	
 366	
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 440	
FIGURE LEGENDS 441	
Figure 1. Perceived ratings of global lower limb soreness (A) and quadriceps soreness (B) 442	
for the LOW, HI and SHAM treatment groups.  Values are presented as mean ± SD. No 443	
significant differences were observed between treatment groups.  ⱡ denotes significant time 444	
effect compared to baseline.   445	
 446	
Figure 2. Percentage change in MVC for the LOW, HI and SHAM treatment groups.  The HI 447	
compression group was significantly different from the SHAM treatment group.  Values are 448	
presented as mean ± SD, data was recorded in newtons and converted to a percentage change. 449	
* denotes a significant difference from the HI group. ⱡ denotes significant time effect 450	
compared to baseline.   451	
 452	
Figure 3. Percentage change in CMJ for the LOW, HI and SHAM treatment groups.  The HI 453	
compression group was significantly different from the LOW compression group at 24 h post 454	
exercise.  Values are presented as mean ± SD. * denotes a significant difference from HI 455	
group. ⱡ denotes significant time effect compared to baseline.  α denotes significant 456	
interaction between HI and LOW compression groups.  457	
 458	
Table 1. Participant characteristics for the low compression pressure group (LOW), high 459	
compression pressure group (HI) and sham ultrasound treatment group (SHAM).  Values are 460	
presented as mean ± SD. 461	
 462	
Table 2. Effect sizes ± 90% CI of the application of treatment on markers of exercise-induced 463	
muscle damage.   464	
 465	
Table 3. Plasma markers of CK, MB and CRP for the LOW, HI and SHAM treatment 466	
groups.  No significant differences were observed between treatment groups.  Values are 467	
presented as mean ± SD.  * denotes significant time effect was observed.  468	
  469	
Table 1. Participant characteristics for the low compression pressure group (LOW), high compression pressure 470	
group (HI) and sham ultrasound treatment group (SHAM).  Values are presented as mean ± SD. 471	
 Age (yrs) Height (cm) Weight (kg) 
LOW 29.2±4.7 173.6±11.7 73.3±17 
HI 32.7±7.8 175±7.4 71.7±7.2 
SHAM 28.3±4.1 174.1±9.4 71.7±10.2 
	472	
	 	473	
Table 2. Effect sizes ± 90% CI of the application of treatment on markers of exercise-induced 474	
muscle damage.   475	
 476	
 Post 24 h 48 h 72 h 
Change from baseline 
Global soreness 
LOW v SHAM 
HI v SHAM 
LOW v HI 
 
 
-0.12±15.7 
0.41±10.9a 
-0.47±13.6 a 
 
-0.12±15.9 
0.36±15.1a 
-0.48±15.2a 
 
0.35±18.8a 
0.55±17.2b 
-0.17±16.9 
 
0.31±14.3a 
0.45±12.8a 
-0.11±11.9 
Quadriceps soreness 
LOW v SHAM 
HI v SHAM 
LOW v HI 
 
 
0.14±15.2 
0.32±13.0a 
-0.18±11.5 
 
-0.28±18.0a 
0.39±16.7a 
-0.74±15.6b 
 
0.09±18.6 
0.47±19.2a 
-0.38±19.1a 
 
0.03±16.3 
0.26±15.6a 
-0.27±14.9a 
MVC 
LOW v SHAM 
HI v SHAM 
LOW v HI 
 
 
-0.02±3.8 
-0.36±3.3a 
0.35±3.2a 
 
-0.33±3.7a 
-0.80±3.7c 
0.53±3.3b 
 
-0.40±3.5a 
-0.92±3.9c 
0.61±3.6b 
 
0.06±4.4 
-0.88±4.0c 
0.86±4.4c 
CMJ 
LOW v SHAM 
HI v SHAM 
LOW v HI 
 
 
0.25±4.2a 
0.10±3.5 
-0.17±4.0 
 
0.60±4.2b 
-0.93±3.6c 
-1.30±4.5c 
 
0.86±4.0c 
-0.01±4.2 
-0.99±3.4c 
 
0.62±3.3b 
-0.38±3.2a 
-1.09±3.0c 
CK 
LOW v SHAM 
HI v SHAM 
LOW v HI 
 
 
-0.46±173.7a 
-0.73±85.4b 
-0.09±190.7 
 
-0.51±99.0b 
-0.27±119.2a 
-0.13±145.8 
 
-0.18±64.8 
-0.14±125.4 
0.05±122.6 
 
-0.79±75.0b 
0.12±153.6 
0.50±155.1b 
Mb  
LOW v SHAM 
HI v SHAM 
LOW v HI 
 
 
0.22±75.7a 
-0.08±92.6 
0.08±84.3 
 
-0.47±96.0a 
-0.26±111.2a 
-0.15±101.1 
 
-0.03±113.2 
0.01±140.6 
-0.03±111.8 
 
-0.73±93.1b 
-0.64±108.5b 
0.01±113.0 
CRP  
LOW v SHAM 
HI v SHAM 
LOW v HI 
 
0.06±0.5 
-0.13±0.5 
0.22±0.4 
 
0.23±0.5 
0.36±0.5 
-0.09±0.5 
 
0.14±0.5 
0.11±0.4 
0.04±0.5 
 
0.10±0.5 
0.02±0.5 
0.07±0.5 
 477	
Mean effect refers to the first names group minus the second named group, a indicates a small effect 478	
size, b indicates a medium effect size, c indicates a large effect size.  479	
  480	
Table 3. Plasma markers of CK, MB and CRP for the LOW, HI and SHAM treatment groups.  Values are 481	
presented as mean ± SD.   482	
 Pre Post 24 h 48 h 72 h 
CK (IU.L-1) 
LOW 
HI 
SHAM 
 
 
184.3±152.3 
207.7±218.6 
217±298.5 
 
418.9±722.3 
401.6±333.4 
258.2±332.9 
 
368±440.7 
345.7±371.4 
277.3±326.4 
 
280±259.8 
318.8±355.3 
284.9±355.4 
 
168.5±82.5 
380.9±438.4 
345.1±579.7 
Mb (ng.ml-1) 
LOW 
HI 
SHAM 
 
 
434.3±107.0 
458±182.2 
490.4±88.5 
 
489.8±186.1 
571.5±155.7 
585.8±180 
 
534.1±204.8 
519.7±145.7 
480±170.2 
 
439.5±155.3 
454.8±261.9 
487.7±158.8 
 
504.1±194.7 
566.7±159 
429.7±128.3 
CRP (pg.mL-1) 
LOW 
HI 
SHAM 
 
2.5±0.7 
2.6±0.7 
2.3±0.5 
 
2.3±0.8 
2.5±0.9 
2.2±0.8 
 
2.4±1.0 
2.3±0.6 
2.5±0.9 
 
2.2±1.0 
2.3±0.9 
2.1±1.0 
 
2.3±0.9 
2.4±1.1 
2.3±1.0 
 483	
  484	
 485	
  486	
 487	
 488	
  489	
 490	
 491	
